Nov. 4 at 2:23 PM
$CC "Heads up alert! Upcoming earnings on Thursday, 11/6/2025 for
$CC
Neutral (5.5)
---
In recent assessments of Chemours (CC), the company's stock has been under significant pressure, reflecting a decline of approximately 22% over the past month and nearly 36% over the past year.
Analysts have pointed to ongoing business challenges and market uncertainties as primary factors affecting investor sentiment.
The company's P/E ratio currently stands at around 12.5, which is relatively low compared to the specialty chemicals sector average of approximately 18.
This suggests that Chemours may be undervalued, especially considering its projected EPS growth of 5% next year, which, while modest, is in line with industry trends.
Revenue forecasts for the upcoming quarters indicate a slight contraction, with expectations of a 3% decrease in Q3 revenues compared to the previous year, driven by weaker demand across several key markets.
Comparatively, industry peers are expected to experience stable growth, highlighting Chemours' challenges in maintaining market share.
The company’s recent price target adjustments from Mizuho and Truist, which raised their targets to
$19 and
$21 respectively, indicate a potential for recovery, albeit contingent on overcoming current operational hurdles.
Analysts continue to view Chemours as a solid investment opportunity, albeit with caution due to its historical volatility and ongoing litigation related to environmental concerns.
---
Looking ahead to the upcoming earnings report, expectations are set for a decline in earnings, with consensus estimates predicting a drop in EPS from
$0.67 in the previous quarter to approximately
$0.60.
Historically, Chemours has exhibited mixed performance during earnings releases, often falling short of analyst expectations in challenging market conditions.
The upcoming report is critical; a significant deviation from these estimates could further impact investor confidence.
Analysts are closely monitoring the company's ability to navigate its operational challenges and stabilize its revenue base, which is essential for any potential upside in stock performance.
---
In terms of sector performance, the specialty chemicals sector has shown resilience, with an average growth rate of 4% across the industry.
This is driven by robust demand in areas such as sustainable materials and advanced manufacturing processes.
However, Chemours' recent struggles highlight the competitive pressures within this sector, particularly regarding regulatory challenges and shifting consumer preferences towards more sustainable products.
The overall sentiment within the sector remains cautiously optimistic, but Chemours' unique challenges may require more strategic repositioning to align with broader industry trends.
- Funds were net buyers of
$CC during the previous reporting quarter.
- Funds with large holdings in
$CC include:
- Scopia Capital Management LP, MV:
$38MM. Fund Rank: 68%
www.scopia.com
- Sir Capital Management LP, MV:
$11MM. Fund Rank: 67%
- Jain Global Llc, MV:
$6MM. Fund Rank: 54%
- Canada Pension , MV:
$5MM. Fund Rank: 78%
- Duquesne Family Office LLC, MV:
$5MM. New position. Fund Rank: 96%
www.duquesne.com
- Last 10 days performance: -1%
- Last 30 days performance: -18%
- Last 90 days performance: 17%
Some of the latest news articles:
- Title: Earnings Preview: Chemours (CC) Q3 Earnings Expected to Decline
Publication Date: 10/30/2025 2:00:05 PM, Source: yahoo
URL: https://finance.yahoo.com/news/earnings-preview-chemours-cc-q3-140005687.html?.tsrc=rss
- Title: Chemours Announces Fourth Quarter Dividend
Publication Date: 10/29/2025 9:00:00 PM, Source: yahoo
URL: https://finance.yahoo.com/news/chemours-announces-fourth-quarter-dividend-210000972.html?.tsrc=rss
- Title: Chemours Announces Dates for Third Quarter 2025 Earnings Release and Webcast Conference Call
Publication Date: 10/16/2025 8:30:00 PM, Source: yahoo
URL: https://finance.yahoo.com/news/chemours-announces-dates-third-quarter-203000900.html?.tsrc=rss
- Title: Chemours (CC): Assessing Valuation After Prolonged Share Price Pressure and Uncertainty
Publication Date: 10/11/2025 3:08:22 PM, Source: yahoo
URL: https://finance.yahoo.com/news/chemours-cc-assessing-valuation-prolonged-150822671.html?.tsrc=rss
Follow us on stocktwits.com for more earnings alerts. Not a financial advice. Not a trading signal."
